scispace - formally typeset
Search or ask a question

How do I know if my lungs are infected with Covid? 

Answers from top 8 papers

More filters
Papers (8)Insight
COVID-19 predominantly involves the lungs, causing DAD and leading to acute respiratory insufficiency.
Males are more likely than females to be infected with COVID-19 and the most occurring symptoms are fever, breathing difficulty, malaise, dry cough and chest pain.
This case demonstrates that leukocyte uptake in bilateral lungs could reveal viral pulmonary infection in COVID-19.
These key determinants of virus entry into the lungs may contribute to the poorer outcomes from COVID-19 disease in patients with severe asthma.
The clinical studies indicate that the severity of COVID-19 cases depends on the virus's amount within infected lungs.
COVID-19 mainly affects the lower lobes of the lungs.
Our data unmask the important lipid storm occurring in the lungs of patients afflicted with severe COVID-19.
Monitoring of symptoms could help to know the viral shedding in children with COVID-19.

See what other people are reading

What is the clinical characteristics of paramyxovirus infections in patients with Acute respiratory illnesses?
4 answers
Paramyxovirus infections in patients with acute respiratory illnesses exhibit distinct clinical characteristics. Human respiratory syncytial virus (HRSV) causes age-related differences in clinical manifestations, with fever, cough, wheezing, and intercostal retractions being common symptoms. Adenovirus infections in hospitalized children show differences in clinical features based on the predominant type, with HAdV-7 causing more severe symptoms than HAdV-3, including wheezing, abnormal white blood cell counts, and longer hospital stays. Inpatients with human adenovirus (HAdV) respiratory infections commonly present with fever, cough, wheezing, and shortness of breath, with HAdV-B3 and HAdV-B7 being the most prevalent types. Paramyxovirus-related pneumonia in adults indicates that RSV-related pneumonia tends to be more severe than hMPV or hPIV-related pneumonia, with distinct clinical features aiding in differentiation.
Where does klebsiella peumoniae isolated?
4 answers
Klebsiella pneumoniae is isolated from various sources including sputum samples, urine, blood, nasal swabs, milk samples, anal and vaginal swabs in different animals like cattle, buffaloes, and calves. It is a prevalent pathogen causing infections in both humans and animals, with a particular presence in hospital settings and among immunocompromised individuals. The bacterium is known for its ability to cause a wide range of diseases such as coliform mastitis, pneumonia, urinary tract infections, and more. Notably, Klebsiella pneumoniae strains exhibit resistance to various antibiotics, with multiple drug-resistant isolates posing a significant challenge in clinical settings. The diverse sources of isolation highlight the ubiquitous nature of Klebsiella pneumoniae and its impact on both animal and human health.
Where does klebsiella peumoniae isolated in human?
5 answers
Klebsiella pneumoniae is commonly isolated in humans from various sources, including urine, blood, and sputum samples. Studies have shown that Klebsiella pneumoniae can cause a spectrum of infections similar to those of Klebsiella quasipneumoniae, with higher rates of susceptibility to many commonly tested antimicrobials and low prevalence of virulence genes. Additionally, Klebsiella pneumoniae has been identified as a common nosocomial pathogen, often causing urinary, respiratory, or generalized infections in healthcare settings, with increasing resistance to antibiotics. Research has also highlighted the importance of the hospital environment as a significant source of Klebsiella pneumoniae associated with serious human infections, emphasizing the role of environmental contamination in the transmission of the pathogen to patients.
What is benefits of vitamin C?
5 answers
Vitamin C offers a multitude of benefits to the human body. It acts as an essential enzyme cofactor for various biochemical reactions, including collagen biosynthesis, carnitine and catecholamine synthesis, and cholesterol metabolism. Furthermore, vitamin C plays a crucial role in antioxidant defense by scavenging reactive oxygen and nitrogen species, modulating iron absorption, and participating in DNA and histone remodeling. Studies have shown that vitamin C intake is associated with reduced risks of all-cause mortality, cardiovascular diseases, and various cancers, while also benefiting respiratory, neurological, musculoskeletal, and renal health outcomes. Additionally, vitamin C has demonstrated promising effects in immune support, skin aging reduction, osteoporosis risk reduction, and as an adjunct treatment in conditions like sepsis and cancer.
Do diabetics have shorter life expectancy compared to non-diabetic people?
4 answers
People with diabetes, both type 1 and type 2, generally have a shorter life expectancy compared to non-diabetic individuals. For individuals aged 45, those with type 1 diabetes live on average 13 years less than those without diabetes, while those with type 2 diabetes live around 4 years less. Diabetes remains a significant risk factor for premature death, with approximately 26.6% of deaths in 2019 being of people with diabetes, resulting in around 40,000 excess deaths compared to the general population. Additionally, individuals with type 2 diabetes treated with metformin showed shorter survival times compared to matched controls over a twenty-year period. The mortality associated with both type 1 and type 2 diabetes leads to a loss of future life years, emphasizing the importance of effective engagement with therapy and lifestyle recommendations.
What are the most effective treatment strategies for managing anemia in tuberculosis patients?
5 answers
Effective treatment strategies for managing anemia in tuberculosis (TB) patients involve a multifaceted approach. Antitubercular therapy plays a crucial role in resolving anemia of infection associated with TB. Iron supplementation may be necessary for cases of iron deficiency anemia (IDA) in TB patients, as TB bacteria's reliance on iron complicates anemia management. Monitoring iron biomarkers like hepcidin and ferritin is essential to guide interventions, with a window for iron-based interventions opening as early as 2 months into TB treatment. Additionally, studies emphasize the importance of measuring hepcidin and ferritin levels to assess anemia severity and response to therapy. Overall, a combination of antitubercular therapy and targeted iron supplementation based on iron biomarker monitoring is crucial for effectively managing anemia in TB patients.
Does having T1DM cause PVD?
5 answers
Having Type 1 Diabetes Mellitus (T1DM) can lead to Peripheral Vascular Disease (PVD). Individuals with T1DM are at a higher risk of developing cardiovascular diseases (CVD), including PVD, compared to the general population. Studies have shown that T1DM patients with poor glycemic control have a significantly elevated risk of morbidity and mortality from CVD, including PVD. Furthermore, the presence of metabolic syndrome (MetS) in T1DM patients increases the likelihood of developing vascular complications, such as PVD, due to factors like obesity, insulin resistance, and poor metabolic control. Therefore, timely detection of MetS in T1DM is crucial for preventing and managing the associated cardiovascular risks, including PVD.
Did black people live near mines during aparthied?
5 answers
During apartheid in South Africa, black mineworkers were typically housed in high-density compounds near the mines, while white workers were accommodated in company-managed towns. The housing arrangements were segregated based on race, with black mineworkers being classified as migrants and residing in single-sex hostels or compounds provided by the mining companies. This segregation in housing was a significant aspect of the mining industry's operations during apartheid, reflecting the discriminatory policies and practices of that era. The living conditions for black mineworkers were often characterized by overcrowding and limited amenities, contributing to the development of informal settlements around the mines.
Cancer continues to be a major public health concern
4 answers
Cancer remains a significant public health concern globally. It is the second leading cause of death after heart disease, with over 200 types classified based on origin. In 2020, approximately 466,000 pancreatic cancer deaths were estimated worldwide, emphasizing the urgent need for improved risk prediction models. Low- and middle-income countries bear the majority of the cancer burden, with inadequate healthcare systems to address the rising incidence rates. The number of cancer survivors in the US continues to increase, highlighting the importance of better serving these individuals through improved care and support. Public fear of cancer from environmental exposures is also a contributing factor to the ongoing concern about cancer as a public health issue.
What are the current prevalence and incidence rates of ischemic heart disease (IHD) globally?
5 answers
The current global prevalence of ischemic heart disease (IHD) is estimated to affect around 126 million individuals, approximately 1.72% of the world's population, with an expected increase to over 1,845 per 100,000 population by 2030. In 2017, there were 10.6 million new cases of IHD, resulting in 8.9 million deaths globally. The burden of IHD remains high, particularly in regions with lower socio-demographic index (SDI), with high systolic blood pressure identified as a significant contributor to disability-adjusted life years (DALYs) globally. Despite the increase in the crude number of IHD cases, the global age-standardized incidence rate of IHD has actually decreased by 27% from 1990 to 2017.
Can the identification and management of anemia improve the treatment outcomes and overall prognosis for tuberculosis patients?
4 answers
Identification and management of anemia in tuberculosis (TB) patients can significantly impact treatment outcomes and prognosis. Anemia is prevalent among TB patients in Africa, with rates ranging from 25% to 99%. Severe anemia in HIV-TB patients is associated with higher mortality risk and increased tuberculosis dissemination. Elevated monocyte levels in TB patients with anemia are linked to poor treatment outcomes and lower cure rates. Although anemia prevalence is high among TB/HIV coinfected patients, especially in sub-Saharan Africa, managing anemia can reduce adverse outcomes and mortality risks. Routine screening for anemia at TB diagnosis, along with appropriate interventions like iron supplementation or diet modifications, can improve treatment outcomes and enhance the overall prognosis for TB patients, particularly those with comorbidities like HIV.